Piper Jaffray Remains Bullish on C.R. Bard Inc. (BCR) Following Investor Day

Piper Jaffray maintained an Overweight rating and $241.00 price target on C.R. Bard, Inc. (NYSE: BCR) following the company's investor day. The company highlighted the substantial investments that it has made in sales and marketing and its broad product pipeline across each of its segments which have the company well-positioned to continue its outperformance.

Analyst Brooks West commented, "Bard held an investor day, which featured a broad overview of its organic growth drivers and was highlighted by a bullish tone from management on its longer-term outlook. While the company did not update any financial guidance, investors did receive some thoughts on the key issue of the Gore royalty expiration in late ’19 and a more granular look at product and geographic opportunities. The overriding theme of the day was the company’s continued focus on sustainable, above-market growth driven by product launches, geographic expansion and acquisitions. With a focus on product quality, patient outcomes, health economic value and macro shifts in the healthcare environment, we continue to view BCR as well positioned to achieve its goals and maintain outperformance. Reiterate our Overweight rating and $241 price target."

For an analyst ratings summary and ratings history on C.R. Bard, Inc. click here. For more ratings news on C.R. Bard, Inc. click here.

Shares of C.R. Bard, Inc. closed at $220.18 yesterday.

You May Also Be Interested In

• META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban
• Symrise AG (SY1:GR) (SYIEY) PT Raised to EUR120 at CFRA
• Inter Parfums (IPAR) PT Lowered to $172 at Piper Sandler